Rani Therapeutics Holdings Inc Capital Reinvestment Ratio

Latest as of September 2020: 0.15x

Rani Therapeutics Holdings Inc capital reinvestment ratio. Rani Therapeutics Holdings Inc (RANI) has a Capital Reinvestment Ratio of 0.15x as of September 2020, meaning it reinvests 0% of its operating cash flow ($670.00K) in capital expenditures ($99.00K). Check Rani Therapeutics Holdings Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.15x

Capex / Operating Cash Flow

Operating Cash Flow

$670.00K

USD

Capital Expenditures

$99.00K

USD

Data as of

Sep 2020

Most recent filing

Rani Therapeutics Holdings Inc Capital Reinvestment Ratio by Year (None–None)

Rani Therapeutics Holdings Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Rani Therapeutics Holdings Inc (RANI) cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow